PharmaSeq

Home Company News & Events Press Releases 2013 PharmaSeq Receives US Patent for p-Chip Injector for Small Animal Tagging

Press Releases

PharmaSeq Receives US Patent for p-Chip Injector for Small Animal Tagging

Monmouth Junction, NJ, January 29, 2013. PharmaSeq, Inc. announced today that is has received a US patent (8,353,917) for an “Apparatus and Method to Deliver a Microchip”. The patent covers the design and use of an injector that is used to implant the Company’s p-Chip® microtransponder under the skin of small animals, such as mice and zebrafish that are used in life science and medical research. The injector, when used as part of a complete system including a proprietary reader and software, provides a low-cost, highly reliable method for tagging and tracking animal subjects through experimental procedures and eliminates errors and identification mix ups. Another particularly valuable aspect of the technology is the enabling of secure chain-of-custody between small animal breeders, research institutions, and institutions that perform preclinical testing.

Dr. Richard Morris, CEO of PharmaSeq, commented: “The issuance of this important patent further demonstrates that the p-Chip can be a high value component in the life science research process. In particular, the use of a small, inexpensive, light-activated microchip for tagging small animal, consumer and industrial products breaks the size and cost barriers that have prevented traditional RFID methods from being more broadly adapted in many areas.” Dr. Morris added: “We believe that p-Chips will eventually be used across a wide variety of industries for tagging small animals, product authentication and product packaging. Their low cost, ruggedness and biocompatibility make them ideal in many fields.”

About PharmaSeq. PharmaSeq, Inc., has developed an ultra-small microtransponder tag called the pChip that will revolutionize several billion-dollar industries. The p-Chip is the smallest, most technologically-advanced commercial product available today for tagging and authenticating consumer goods, industrial goods and small animals. It is at least 100-fold smaller than current gold standard RFID tags and is far less to manufacture in volume – an order of magnitude less expensive than tags commonly used today. The p-Chip is nearly impossible to counterfeit and can be used reliably in environmentally-challenging conditions ranging from -190°C to 200°C. These four unique capabilities of the p-Chip significantly expand the addressable market for this highly advanced, foundational technology. For additional information, visit www.pharmaseq.com.

For further information, please contact Dr. Richard G. Morris, CEO, at (732) 355-0100.


PharmaSeq, Inc.
11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852


Find us on the web at: www.pharmaseq.com.


Home Company News & Events Press Releases 2013 PharmaSeq Receives US Patent for p-Chip Injector for Small Animal Tagging